<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Nutritional composition of human milk and preterm formula for the premature infant
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Nutritional composition of human milk and preterm formula for the premature infant
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Nutritional composition of human milk and preterm formula for the premature infant
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Camilia R Martin, MD, MS
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Steven A Abrams, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alison G Hoppin, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Dec 14, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Human milk is the recommended diet for the preterm infant. However, the preterm infant is metabolically and nutritionally challenged as it transitions from in utero to an external environment of intensive care to support organ function and growth. To support these functions, it may be necessary to fortify raw milk to deliver required levels of specific nutrients  (
         <a class="graphic graphic_table graphicRef60637" href="/z/d/graphic/60637.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         This topic review will discuss the components of human milk and preterm formula and compare these with the nutritional requirements of the premature infant. Other issues relevant to enteral nutrition for premature infants are covered in the following topic reviews:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5050.html" rel="external">
          "Human milk feeding and fortification of human milk for premature infants"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5014.html" rel="external">
          "Approach to enteral nutrition in the premature infant"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5035.html" rel="external">
          "Breastfeeding the preterm infant"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5056.html" rel="external">
          "Management of bone health in preterm infants"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          OVERVIEW
         </span>
         <span class="headingEndMark">
          —
         </span>
         The nutrient content in human milk varies substantially between and within lactating women, depending on lactational stage, time of expression, maternal characteristics, and method used for pasteurization. Additionally, nutrient content differs between mother's own milk (unpasteurized), donor milk (pasteurized), commercially available preterm formulas, and human milk fortifiers (HMFs). The unique nutritional needs of a premature infant determines the nutritional strategy, which may require the use of one or more of these dietary options.
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          PROTEIN
         </span>
        </p>
        <p class="headingAnchor" id="H4017244232">
         <span class="h2">
          Requirements and fortification
         </span>
         <span class="headingEndMark">
          —
         </span>
         Recommended protein intake for fully enterally fed preterm infants is 3.5 to 4.5 g/kg/day (or 3.2 to 4.1 g/100 kcal)  (
         <a class="graphic graphic_table graphicRef60637" href="/z/d/graphic/60637.html" rel="external">
          table 1
         </a>
         ). Higher protein intake (&gt;4.0 g/kg/day) may be considered for those with growth failure [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fortified human milk
         </strong>
         – Human milk must be fortified to achieve an adequate protein intake within the feeding volume that can reasonably be delivered to a very low birth weight infant. Protein content in unpasteurized human milk ranges from 1.5 to 2.2 g/dL during the first one to two postnatal weeks and then decreases to 1.0 to 1.4 g/dL at three weeks and later (mature milk)  (
         <a class="graphic graphic_table graphicRef111635" href="/z/d/graphic/111635.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid2">
          2
         </a>
         ]. At the lower end of this range of protein concentration (1 g/dL), a fully enterally fed preterm infant with a weight of 1000 g would need to ingest 350 to 450 mL/day, which is more than double the volume that is tolerated by most preterm infants. Fortifying the human milk by adding a human milk fortifier (HMF) increases the protein content of the feed to 2.5 to 3.25 g/dL (using a bovine-based HMF) or to 1.9 to 3.5 g/dL (using a human milk-based HMF)  (
         <a class="graphic graphic_table graphicRef130184" href="/z/d/graphic/130184.html" rel="external">
          table 3
         </a>
         ). Thus, a fortified feed provides sufficient protein in a volume of 120 to 150 mL/day, which is typically tolerated by preterm infants.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preterm formula
         </strong>
         – In preterm infant formula, protein concentrations range from 2.2 to 3.3 g/dL, depending on caloric density, manufacturer, and formulation (standard versus high protein).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Whey versus casein
         </span>
         <span class="headingEndMark">
          —
         </span>
         The protein content in human milk is distributed among three compartments. The majority of proteins are in the whey or casein fractions, with a small amount in the lipid fraction, residing within the fat globule cell membranes [
         <a href="#rid3">
          3
         </a>
         ]. The whey and casein fractions differ in their physical properties and representative proteins.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Whey
         </strong>
         – The whey fraction is the soluble, non-curdled fraction of milk after acidification or fermentation and provides approximately 20 percent of milk protein [
         <a href="#rid4">
          4
         </a>
         ]. These include alpha-lactalbumin, lactoferrin, lactoperoxidase, and lysozyme, as well as hundreds of other whey proteins that are less well characterized [
         <a href="#rid4">
          4,5
         </a>
         ]. These whey proteins have several immunomodulatory and gastrointestinal functions.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Casein
         </strong>
         – The casein fraction in milk is the curdled portion after the acidification or fermentation of milk. It is the smaller fraction but is protein dense so that it provides approximately 80 percent of milk protein [
         <a href="#rid4">
          4
         </a>
         ]. There are three major subunits of caseins: alpha (a)-, beta (b)-, and kappa (k)-caseins. Bovine and human milk contain all three subunits, but a-caseins represent only a small component in human milk [
         <a href="#rid4">
          4,5
         </a>
         ]. b-casein is the most prevalent of the three subunits in both bovine and human milk [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Casein polypeptide chains include bioactive peptides, which have several important actions, including immunomodulatory and antibacterial properties, antithrombotic and antihypertensive activity, effects on gastrointestinal motility, and opioid receptor agonism, as determined by in vitro studies [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H103240152">
         <span class="h2">
          Whey:casein ratio
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Human milk
         </strong>
         – The whey:casein ratio in human milk is approximately 80:20, with only a slight decline during lactation, as determined by a study using modern and precise methods [
         <a href="#rid5">
          5
         </a>
         ]. This is in contrast with historical reference values, which suggested that the whey:casein ratio in mature human milk is 60:40 or 50:50 [
         <a href="#rid6">
          6
         </a>
         ]. However, as with all nutrients in human milk, there is tremendous interindividual variation in the whey:casein ratio.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preterm formula
         </strong>
         – The whey:casein ratios in formula vary by brand and type. In general, formulas for preterm infants typically have ratios of 80:20. The high whey:casein ratio is designed to make the preterm formula similar to human milk and is thought to improve digestibility compared with formulas with lower ratios (eg, 60:40, which is typical for term infant formulas) [
         <a href="#rid7">
          7
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h2">
          Amino acid composition
         </span>
         <span class="headingEndMark">
          —
         </span>
         The amino acid profile of human milk has a somewhat different amino acid profile and more free amino acids compared with preterm formula. These differences may explain some of the physiologic and health benefits of human milk over formula.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Human milk
         </strong>
         – Most of the amino acids in human milk are in the whey and casein proteins. Glutamic acid is the predominant amino acid [
         <a href="#rid8">
          8
         </a>
         ], followed by serine, taurine, glutamine, alanine, and aspartic acid [
         <a href="#rid8">
          8,9
         </a>
         ]. Essential amino acids (ie, amino acids that cannot be synthesized from other amino acids) are well represented, especially isoleucine, leucine, lysine, threonine, and valine [
         <a href="#rid8">
          8
         </a>
         ]. The amino acid profile varies by the whey and casein components [
         <a href="#rid5">
          5
         </a>
         ]. In general, concentrations of arginine, cystine, lysine, methionine, and tryptophan are greater in whey versus casein and, thus, these amino acids are more prominent in samples with high whey:casein ratios [
         <a href="#rid10">
          10,11
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In addition, 10 to 25 percent of the nitrogen in human milk is nonprotein nitrogen. Sources of nonprotein nitrogen include urea (almost one-half of total nonprotein nitrogen), creatinine, nitrogen-containing oligosaccharides, nucleic acids, and free amino acids [
         <a href="#rid12">
          12
         </a>
         ]. Of the free amino acids, glutamine, glutamate, and taurine are the most abundant [
         <a href="#rid8">
          8,13,14
         </a>
         ]. Free amino acids are beneficial to the developing infant because they are rapidly absorbed and serve as nitrogen sources and substrates for neurotransmitters and antioxidants, provide energy substrates for the developing gut, and support immune development [
         <a href="#rid14">
          14,15
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Total protein and free amino acid concentrations are higher in preterm versus term milk [
         <a href="#rid13">
          13
         </a>
         ]. Additionally, as lactation progresses, the pool of free amino acids decreases, except that the absolute concentrations increase for glutamic acid, glutamine, serine, alanine, and cystine [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preterm formula
         </strong>
         – The amino acid profile of formula depends in part on its whey:casein ratio. Preterm formulas include additional bovine whey so that the whey:casein ratio more closely resembles human milk. Nonetheless, the amino acid profile differs, reflecting the profile of bovine whey compared with human whey. In addition, formulas have a lower content of nonprotein nitrogen (approximately 5 percent) and, in contrast with human milk, the predominant free amino acids are taurine and methionine.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3128499376">
         <span class="h1">
          LIPIDS
         </span>
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Requirements and fortification
         </span>
         <span class="headingEndMark">
          —
         </span>
         The recommended fat intake for fully enterally fed preterm infants is 4.8 to 6.6 g/kg/day (or 4.4 to 6.0 g/100 kcal)  (
         <a class="graphic graphic_table graphicRef60637" href="/z/d/graphic/60637.html" rel="external">
          table 1
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fortified human milk
         </strong>
         – Human milk usually requires fortification to achieve an adequate intake of fat. Fat content in unpasteurized human milk varies widely, from approximately 2.6 to 3.7 g/dL [
         <a href="#rid2">
          2
         </a>
         ]. Assuming a fat concentration of 3 g/dL, a fully enterally fed preterm infant weighing 1000 g would need to ingest 160 to 220 mL/day to meet the target for fat intake. This volume is near or above the volume that most preterm infants can tolerate, even when they are healthy. Fortifying the human milk by adding a human milk fortifier (HMF) increases the fat content of the feed to 4.4 to 4.8 g/dL (using a bovine-based HMF) or to 4.7 to 6.4 g/dL (using a human milk-based HMF). Thus, a fortified feed provides sufficient fat in a volume of 100 to 140 mL/day, which is typically tolerated by these infants. (See
         <a class="medical medical_review" href="/z/d/html/5050.html" rel="external">
          "Human milk feeding and fortification of human milk for premature infants", section on 'Fortification of human milk'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preterm formula
         </strong>
         – In preterm infant formula, fat concentrations vary by manufacturer and caloric density, ranging from 3.4 to 6.7 g/dL.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H703992403">
         <span class="h2">
          Total fat content
         </span>
         <span class="headingEndMark">
          —
         </span>
         Total fat represents 3.9 percent of human milk [
         <a href="#rid16">
          16
         </a>
         ] and provides up to 40 to 50 percent of total energy intake through the first six months of age [
         <a href="#rid17">
          17,18
         </a>
         ]. Total fat content is generally higher in preterm compared with term milk  (
         <a class="graphic graphic_table graphicRef111635" href="/z/d/graphic/111635.html" rel="external">
          table 2
         </a>
         ) [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p>
         The fat content in human milk demonstrates the highest interindividual variation among the three major macronutrients (fat, protein, and carbohydrates), with a coefficient of variation of almost 40 percent [
         <a href="#rid18">
          18
         </a>
         ]. Fat content also varies substantially among samples produced by an individual woman, with higher fat content in:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         More mature milk (peaking after three weeks postpartum [
         <a href="#rid2">
          2
         </a>
         ], subsequently decreasing by six months postpartum [
         <a href="#rid18">
          18
         </a>
         ])
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Later in the day [
         <a href="#rid19">
          19,20
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Longer duration of a feeding [
         <a href="#rid18">
          18
         </a>
         ]
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Longer interval between feedings
        </p>
        <p>
        </p>
        <p>
         In one series of term milk samples, the average total fat concentration in milk expressed early in the feeding (foremilk) was 3.2 g/dL, compared with 5.6 g/dL in milk expressed later in the feeding (hindmilk) [
         <a href="#rid21">
          21
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2426537866">
         <span class="h2">
          Triglycerides
         </span>
         <span class="headingEndMark">
          —
         </span>
         Almost all lipids in human milk are packaged as triglycerides (also known as triacylglycerides), which are comprised of three fatty acid chains on a glycerol backbone [
         <a href="#rid18">
          18
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Classification
         </strong>
         – Fatty acids are classified by [
         <a href="#rid22">
          22
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Carbon chain length:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Short-chain fatty acids have 2 to 5 carbons
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Medium-chain fatty acids have 6 to 12 carbons
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Long-chain fatty acids have 13 to 21 carbons
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Very long-chain fatty acids have 22 or more carbons
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Degree of "saturation":
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Saturated fatty acids have only single bonds between carbons (ie, a maximum number of hydrogens per carbon)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Monounsaturated fatty acids have one double bond between carbons
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Polyunsaturated fatty acids have multiple double bonds between carbons
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Key lipids in human milk
         </strong>
         – Eighty-five percent of fatty acids in human milk are saturated or monounsaturated, while polyunsaturated fatty acids represent 15 percent [
         <a href="#rid17">
          17,18
         </a>
         ]. Each of these classes has important health benefits for the preterm infant.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Saturated fatty acids – Palmitic acid (C16:0) is by far the most common saturated fatty acid in human milk and represents 20 to 25 percent of all fatty acids throughout lactation  (
         <a class="graphic graphic_table graphicRef130395" href="/z/d/graphic/130395.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid17">
          17
         </a>
         ]. The form of palmitic acid differs slightly between human milk (in which most is esterified in the sn-2 position) compared with formulas (in which it is esterified in the 1,3 position). Clinical implications of this distinction have not been determined, although an association between sn-2 esterification and softer stool consistency has been suggested based on low-quality evidence [
         <a href="#rid23">
          23
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Monounsaturated fatty acids – Oleic acid (C18:1n-9) is a monosaturated fatty acid and represents 30 to 36 percent of the fatty acids in human milk throughout lactation.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Long-chain polyunsaturated fatty acids (LCPUFAs) – LCPUFAs represent 15 percent of all fatty acids in human milk  (
         <a class="graphic graphic_table graphicRef130395" href="/z/d/graphic/130395.html" rel="external">
          table 4
         </a>
         ). They can be grouped as omega-3 (n-3) or omega-6 (n-6) fatty acids depending on the position of the double bond. Arachidonic acid (ARA; n-6) and docosahexaenoic acid (DHA; n-3) are important components of neural tissue and are therefore important for neurodevelopment. Both ARA and DHA are represented in human milk in small amounts, with larger amounts of the ARA precursor, linoleic acid.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         Since the early 2000s, infant formulas, including those intended for preterm infants, have been routinely supplemented with ARA and DHA, although systematic meta-analysis has not shown clear health benefits of this strategy [
         <a href="#rid24">
          24
         </a>
         ]. The possible effects and limited clinical evidence are discussed in a separate topic review. (See
         <a class="medical medical_review" href="/z/d/html/83231.html" rel="external">
          "Long-chain polyunsaturated fatty acids (LCPUFA) for preterm and term infants"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Medium-chain fatty acids or medium-chain triglycerides (MCTs) represent a small proportion of human milk [
         <a href="#rid17">
          17
         </a>
         ]. In contrast, MCTs represent up to 50 percent of total fat in formula in an effort to compensate for the impaired fat digestion in infants and increase overall absorption of fats and energy delivery to optimize growth [
         <a href="#rid25">
          25
         </a>
         ]. However, despite these theoretical benefits, increasing the MCT content in infant formula has not been associated with improved growth [
         <a href="#rid26">
          26
         </a>
         ]. (See
         <a class="local">
          'Delivery and digestibility of lipids'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3334701368">
         <span class="h2">
          Complex lipids
         </span>
         <span class="headingEndMark">
          —
         </span>
         Complex lipids represent 0.2 to 1 percent of total lipids, with a concentration of 100 to 400 mg/L [
         <a href="#rid18">
          18,27
         </a>
         ]. Although this is a small fraction compared with triglycerides, it includes several substances with critical biologic roles, including cholesterol, sphingolipids (eg, ceramides), gangliosides, phospholipids, and plasmalogens.
        </p>
        <p class="headingAnchor" id="H703992469">
         <span class="h2">
          Delivery and digestibility of lipids
         </span>
        </p>
        <p class="headingAnchor" id="H2246370035">
         <span class="h3">
          Milk fat globule membranes
         </span>
         <span class="headingEndMark">
          —
         </span>
         In human milk, lipids are packaged in milk fat globules, a tri-membrane globule in which complex lipids and critical bioactive proteins are embedded into the outer membrane [
         <a href="#rid17">
          17,18
         </a>
         ]. Possible benefits from these complex lipid and protein components, and improved delivery of fats compared with free lipids, have been suggested but not established. Several randomized trials in full-term infants found that infants fed formula supplemented with milk fat globule membranes and lactoferrin had higher scores on measures of cognitive development at 12 to 18 months of age [
         <a href="#rid28">
          28-30
         </a>
         ]. In long-term follow-up in mid-childhood, one of these trials reported persistent cognitive benefits, while the other found no difference [
         <a href="#rid31">
          31,32
         </a>
         ]. The trial showing a benefit had a follow-up of approximately 40 percent of the original cohort, which may limit its interpretation [
         <a href="#rid31">
          31
         </a>
         ].
         <em>
         </em>
         Milk fat globule membrane-supplemented formula has not been directly compared with human milk, and no trials have been conducted in preterm infants.
        </p>
        <p class="headingAnchor" id="H2250221790">
         <span class="h3">
          Pancreatic lipase
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants are born with developmental pancreatic insufficiency, with inefficient hydrolysis and absorption of fats due to limited pancreatic production and excretion of lipase. In mother's own milk, pancreatic enzymes are present, which aid in infant digestion of fats. By contrast, formula lacks digestive enzymes and pasteurization of human milk destroys these digestive enzymes. As a result, hydrolysis and absorption of triglyceride fatty acids is reduced for pasteurized human milk and formula compared with mother's own milk [
         <a href="#rid33">
          33
         </a>
         ].
        </p>
        <p>
         Supplementation of formula or pasteurized human milk with pancreatic enzymes is not recommended for preterm infants. In a randomized trial, administration of recombinant lipase did not improve growth outcomes and increased risk of gastrointestinal complications [
         <a href="#rid34">
          34
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          CARBOHYDRATES
         </span>
        </p>
        <p class="headingAnchor" id="H3952648645">
         <span class="h2">
          Requirements and fortification
         </span>
         <span class="headingEndMark">
          —
         </span>
         The recommended carbohydrate intake in fully enterally fed preterm infants is 11.6 to 13.2 g/kg/day (or 10.5 to 12 g/100 kcal) [
         <a href="#rid1">
          1
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fortified human milk
         </strong>
         – Human milk often requires fortification to achieve the recommended intake of carbohydrates. The carbohydrate content of unpasteurized mother's own milk is approximately 7.0 to 7.3 g/dL [
         <a href="#rid1">
          1,35
         </a>
         ]. To meet this requirement, a fully enterally fed preterm infant with a weight of 1000 g would need to ingest approximately 170 mL/kg/day, which is more than some infants can tolerate. Thus, fortification of human milk may be necessary to meet the goals for carbohydrate intake, in addition to the goals for other macronutrients, as outlined above. Fortifying the human milk by adding a human milk fortifier (HMF) increases the carbohydrate content of the feed to approximately 8.7 g/dL (using a bovine-based HMF) or 8.2 to 8.5 g/dL (using a human milk-based HMF).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Preterm formula
         </strong>
         – The carbohydrate content in preterm infant formula varies by manufacturer and ranges from 7.0 to 10.9 g/dL.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H354154608">
         <span class="h2">
          Lactose
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lactose, a disaccharide chain of glucose and galactose, is the predominant carbohydrate in human milk, representing 70 to 85 percent of carbohydrates [
         <a href="#rid36">
          36
         </a>
         ], and in many standard term formulas. Lactose concentrations in human milk increase during lactation [
         <a href="#rid36">
          36
         </a>
         ]. Compared with term infants, preterm infants are less able to digest lactose because of their developmental deficiency of lactase. Among infants with gestational age 26 to 34 weeks, lactase is only 30 percent of term levels [
         <a href="#rid37">
          37,38
         </a>
         ].
        </p>
        <p>
         Because preterm infants have limited ability to digest lactose, formula manufacturers typically replace some of the lactose with corn syrup and short-chain
         <a class="drug drug_general" data-topicid="8956" href="/z/d/drug information/8956.html" rel="external">
          glucose polymers
         </a>
         . However, even when it is malabsorbed in the small intestine, lactose has important biologic benefits:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lactose that escapes digestion in the small intestine may undergo bacterial fermentation and absorption in the colon, a process known as the colonic salvage pathway
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lactose in the colon enhances intestinal growth of the beneficial microbiota,
         <em>
          Lactobacillus
         </em>
         and
         <em>
          Bifidobacteria
         </em>
         [
         <a href="#rid39">
          39
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lactose increases intestinal absorption of calcium [
         <a href="#rid40">
          40
         </a>
         ], zinc [
         <a href="#rid41">
          41
         </a>
         ], and magnesium [
         <a href="#rid41">
          41
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1060372627">
         <span class="h2">
          Oligosaccharides
         </span>
         <span class="headingEndMark">
          —
         </span>
         Oligosaccharides are short-chain, complex carbohydrates. They have several important biologic benefits, including prebiotic (ie, promoting growth of beneficial microbiota), immunomodulatory, and antimicrobial functions [
         <a href="#rid42">
          42
         </a>
         ].
        </p>
        <p>
         Human milk contains hundreds of different oligosaccharide variants or types, and this is unique to human milk compared with other mammalian milks. The oligosaccharide concentration is high in colostrum and falls as milk matures [
         <a href="#rid36">
          36
         </a>
         ]. However, the oligosaccharide profile remains fairly consistent throughout lactation, suggesting that it is determined by intrinsic genetic factors rather than exogenous factors such as maternal health and diet [
         <a href="#rid36">
          36
         </a>
         ].
        </p>
        <p>
         Like other human milk components, the oligosaccharide component varies between individuals. Limited evidence suggests that variation in the oligosaccharide profile of mother's milk may contribute to the infant's risk for certain morbidities, such as necrotizing enterocolitis. As an example, lower concentrations of disialyllacto-N-tetraose (DSLNT) in mother's milk were associated with an increased risk of necrotizing enterocolitis in a population of preterm infants with a birth weight &lt;1500 g [
         <a href="#rid43">
          43,44
         </a>
         ].
        </p>
        <p>
         Several randomized trials in term infants have evaluated the effects of supplementing infant formula with synthetic oligosaccharides. Infants fed the oligosaccharide-supplemented formula had intestinal microbiota patterns similar to breastfed infants, reduced plasma inflammatory cytokines, reduced respiratory infections, and reduced use of antibiotics [
         <a href="#rid45">
          45-49
         </a>
         ]. In formula-fed moderately preterm infants, small studies found that oligosaccharide supplements improved enteral tolerance; increased intestinal bifidobacteria colonization; and decreased stool viscosity, pH, and frequency [
         <a href="#rid50">
          50-53
         </a>
         ]. In contrast, they were no differences, compared with controls, in markers of intestinal inflammation, intestinal permeability, infectious morbidity, or vaccine responsiveness [
         <a href="#rid54">
          54-58
         </a>
         ]. Large studies of oligosaccharide supplementation in the feedings of extremely preterm infants are lacking.
        </p>
        <p class="headingAnchor" id="H3978162230">
         <span class="h1">
          DONOR MILK
         </span>
         <span class="headingEndMark">
          —
         </span>
         Milk from human donors must be pasteurized to reduce the risk of biologic hazards, in addition to other safety measures [
         <a href="#rid59">
          59,60
         </a>
         ]. The type of pasteurization process, in addition to the age of the donor, has some effects on the nutrient content of donor milk. Compared with typical mother's own milk, donor milk has decreased protein, decreased digestive enzyme activity, and decreased concentration of long-chain polyunsaturated fatty acids (LCPUFAs). (See
         <a class="medical medical_review" href="/z/d/html/5050.html" rel="external">
          "Human milk feeding and fortification of human milk for premature infants", section on 'Use of donor milk'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4182751313">
         <span class="h1">
          ELECTROLYTES, TRACE ELEMENTS, MINERALS, AND VITAMINS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nutrient requirements for preterm infants are summarized in the table  (
         <a class="graphic graphic_table graphicRef60637" href="/z/d/graphic/60637.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p class="headingAnchor" id="H1928695149">
         <span class="h2">
          Sodium
         </span>
         <span class="headingEndMark">
          —
         </span>
         Sodium requirements in the preterm infant are 69 to 115 mg/kg/day (3 to 5 mEq/kg/day) or 63 to 105 mg/100 kcal (2.7 to 4.6 mEq/100 kcal) [
         <a href="#rid1">
          1
         </a>
         ]. Late-onset hyponatremia (serum sodium concentrations &lt;130 mmol/L after the second postnatal week) is common, occurring in up to 20 percent of preterm infants. Infants fed only human milk or fortified human milk are at greater risk compared with infants who are fully or partially formula fed. The most immature infants are at greatest risk, with up to 40 percent of infants with a birth weight &lt;1000 g experiencing late-onset hyponatremia.
        </p>
        <p>
         Sodium content in early preterm milk is higher compared with term milk but rapidly falls during the first two postnatal weeks to term levels (approximately 12 to 25 mg/dL) [
         <a href="#rid61">
          61,62
         </a>
         ]. Fortifying the human milk by adding a human milk fortifier (HMF) adds an additional 27.6 to 41.4 mg/dL (1.2 to 1.8 mEq/dL) for bovine-based HMF or 50.6 to 55.2 mg/dL (2.2 to 2.4 mEq/dL) for human milk-based HMF. However, even after fortification of human milk, preterm infants occasionally require an additional 45 to 140 mg/kg/day (2 to 6 mEq/kg/day) of sodium, typically provided by adding sodium chloride supplements to the feed (eg, a 23.4%
         <a class="drug drug_pediatric" data-topicid="12796" href="/z/d/drug information/12796.html" rel="external">
          saline
         </a>
         solution supplies 4 mEq/mL). The risk for late-onset hyponatremia and need for additional sodium supplementation typically continues for the first one to two months of life. Most infants no longer need sodium supplements by the time of hospital discharge [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p>
         The sodium content in preterm formula is 30 to 71 mg/dL (1.3 to 3.1 mEq/dL). Although preterm formula provides more sodium than does unfortified human milk, some formula-fed infants may still develop late-onset hyponatremia and require sodium supplements.
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h2">
          Calcium and phosphorus
         </span>
         <span class="headingEndMark">
          —
         </span>
         Calcium requirements are approximately 150 to 220 mg/kg/day, and phosphorus requirements are 75 to 140 mg/kg/day [
         <a href="#rid64">
          64
         </a>
         ].
        </p>
        <p>
         Human milk must be supplemented with calcium and phosphorus to meet these needs and support bone development in the preterm infant. Routine supplementation with these minerals has dramatically reduced the risk of rickets and incidental fractures. However, preterm infants have an increased risk of metabolic bone disease despite supplementation; the risk is inversely proportional to gestational age and birth weight. Indeed, 40 to 60 percent of extremely low gestational age newborns will have radiologic and/or biochemical evidence of metabolic bone disease [
         <a href="#rid65">
          65,66
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5056.html" rel="external">
          "Management of bone health in preterm infants"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2654245533">
         <span class="h2">
          Vitamin D and iron
         </span>
         <span class="headingEndMark">
          —
         </span>
         Human milk is low in vitamin D and iron. Preterm infants fed human milk require supplementation to meet their needs. (See
         <a class="medical medical_review" href="/z/d/html/5035.html" rel="external">
          "Breastfeeding the preterm infant", section on 'Vitamin D and iron supplements'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2102521384">
         <span class="h2">
          Other vitamins and minerals
         </span>
         <span class="headingEndMark">
          —
         </span>
         Human milk does not contain sufficient quantities of zinc, potassium, and magnesium to meet the needs of premature infants; these nutrients are generally included in HMFs and preterm formulas. The recommended intakes of these and other nutrients are listed in the table  (
         <a class="graphic graphic_table graphicRef60637" href="/z/d/graphic/60637.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
         Zinc requirements for preterm infants are approximately 1.4 to 2.5 mg/kg/day, which is substantially more than the amount supplied by feeds of unfortified human milk [
         <a href="#rid1">
          1
         </a>
         ]. These requirements are based primarily on micronutrient balance studies and indirect evidence from other populations for which zinc is important for growth and immune function [
         <a href="#rid67">
          67
         </a>
         ], as well as limited clinical evidence for growth benefits in preterm infants [
         <a href="#rid68">
          68,69
         </a>
         ]. Higher supplemental doses have no demonstrated benefit and may adversely affect copper absorption.
        </p>
        <p class="headingAnchor" id="H1083262351">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/111345.html" rel="external">
          "Society guideline links: Breastfeeding and infant nutrition"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Overview
         </strong>
         – Human milk is the recommended diet for the preterm infant. Human milk supplies most essential nutrients as well as some biologically active components that support optimal physical and neurologic development, immune function, and a healthy microbiome and also help to prevent morbidities such as necrotizing enterocolitis. (See
         <a class="local">
          'Overview'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Compared with term infants, preterm infants have markedly higher requirements for certain nutrients. Recommended intakes for very low birth weight infants are shown in the table  (
         <a class="graphic graphic_table graphicRef60637" href="/z/d/graphic/60637.html" rel="external">
          table 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fortification of human milk
         </strong>
         – Despite its advantages, human milk does not supply sufficient amounts of certain nutrients within the feeding volume that is tolerated by preterm infants  (
         <a class="graphic graphic_table graphicRef111635" href="/z/d/graphic/111635.html" rel="external">
          table 2
         </a>
         ). Therefore, supplementation with a human milk fortifier (HMF) is necessary to supply sufficient protein, calcium, phosphorus, and sodium to support growth and to prevent metabolic bone disease and late-onset hyponatremia. The content of these nutrients in unfortified and fortified human milk is outlined in the table  (
         <a class="graphic graphic_table graphicRef130184" href="/z/d/graphic/130184.html" rel="external">
          table 3
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5056.html" rel="external">
          "Management of bone health in preterm infants", section on 'Calcium and phosphorus requirements'
         </a>
         and
         <a class="local">
          'Sodium'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         HMFs also provide supplemental zinc, potassium, and magnesium to meet the estimated needs of preterm infants. (See
         <a class="local">
          'Other vitamins and minerals'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5050.html" rel="external">
          "Human milk feeding and fortification of human milk for premature infants"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Protein
         </strong>
         – Human milk has a higher whey:casein ratio (approximately 80:20) compared with cow's milk. In addition, 10 to 25 percent of the protein in human milk is nonprotein nitrogen, including free amino acids, which are beneficial to the preterm infant because they are more rapidly absorbed. Preterm formulas include additional bovine whey so that the whey:casein ratio resembles human milk, but the amino acid profile still differs from human milk and nonprotein nitrogen is lower. The protein content of human milk decreases substantially as lactation progresses. (See
         <a class="local">
          'Protein'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Lipids
         </strong>
         – The lipid content of human milk varies markedly between women and between samples from an individual woman. Fat content generally increases during lactation (more mature milk) and is higher in samples collected later in the day, with longer inter-feeding intervals, or at the end of a feed (hindmilk). Almost all lipids in human milk are various forms of triglycerides (short-, medium-, or long-chain; saturated, mono-, or polyunsaturated). Small but biologically important components of fats are complex lipids (including cholesterol and sphingolipids). (See
         <a class="local">
          'Lipids'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Carbohydrates
         </strong>
         – Lactose is the predominant carbohydrate in human milk. Because preterm infants have a developmental lactase deficiency, they may not be able to absorb all of the lactose in a human milk feed. However, malabsorbed lactose may be fermented and absorbed in the colon (colonic salvage) and also promotes development of healthy colonic microbiota. Human milk also contains oligosaccharides. These short-chain, complex carbohydrates have several important biologic benefits, including prebiotic (ie, promoting growth of beneficial microbiota), immunomodulatory, and antimicrobial functions. (See
         <a class="local">
          'Carbohydrates'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H995069734">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Richard J Schanler, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li class="breakAll">
          Nutritional Care of Preterm Infants: Scientific Basis and Practical Guidelines, Koletzko B, Poindexter B, Uauy R (Eds), Karger, 2014.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gidrewicz DA, Fenton TR. A systematic review and meta-analysis of the nutrient content of preterm and term breast milk. BMC Pediatr 2014; 14:216.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Golinelli LP, Del Aguila EM, Flosi Pascohalin MF, et al. Functional Aspect of Colostrum and Whey Proteins in Human Milk. J Hum Nutr Food Sci 2014; 2:1035.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shah NP. Effects of milk-derived bioactives: an overview. Br J Nutr 2000; 84 Suppl 1:S3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Liao Y, Weber D, Xu W, et al. Absolute Quantification of Human Milk Caseins and the Whey/Casein Ratio during the First Year of Lactation. J Proteome Res 2017; 16:4113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kunz C, Lönnerdal B. Re-evaluation of the whey protein/casein ratio of human milk. Acta Paediatr 1992; 81:107.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Billeaud C, Guillet J, Sandler B. Gastric emptying in infants with or without gastro-oesophageal reflux according to the type of milk. Eur J Clin Nutr 1990; 44:577.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Csapo J, Salamon SZ. Composition of the mother’s milk I. Protein contents, amino acid composition, biological value. A review. Acta Univ Sapientiae Alimentaria 2009; 2:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pamblanco M, Portolés M, Paredes C, et al. Free amino acids in preterm and term milk from mothers delivering appropriate- or small-for-gestational-age infants. Am J Clin Nutr 1989; 50:778.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beach EF, Bernstein SS, Hoffman OD, et al. Distribution of nitrogen and protein amino acids in human and in cow's milk. J Biol Chem 1941; 139:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Williamson MB. The amino acid composition of human milk proteins. J Biol Chem 1944; 156:47.
          </a>
         </li>
         <li class="breakAll">
          Lonnerdal B. Nestle Nutrition Institute. Nutritional Importance of Non-protein Nitrogen. 1994. Available at: https://www.nestlenutrition-institute.org/docs/default-source/global-dcoument-library/publications/secured/881688262da4f2f175f72c4f110412ce.pdf?sfvrsn=e9e48fdc_0 (Accessed on April 07, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang Z, Adelman AS, Rai D, et al. Amino acid profiles in term and preterm human milk through lactation: a systematic review. Nutrients 2013; 5:4800.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Agostoni C, Carratù B, Boniglia C, et al. Free glutamine and glutamic acid increase in human milk through a three-month lactation period. J Pediatr Gastroenterol Nutr 2000; 31:508.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van Sadelhoff JHJ, Wiertsema SP, Garssen J, Hogenkamp A. Free Amino Acids in Human Milk: A Potential Role for Glutamine and Glutamate in the Protection Against Neonatal Allergies and Infections. Front Immunol 2020; 11:1007.
          </a>
         </li>
         <li class="breakAll">
          National Dairy Council. Technical Report: Understanding the Role of Dairy Proteins in Ingredient and Product Performance. 2015. Available at: https://www.thinkusadairy.org/resources-and-insights/resources-and-insights/application-and-technical-materials/technical-report-understanding-the-role-of-dairy-proteins-in-product-performance (Accessed on December 27, 2020).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramiro-Cortijo D, Singh P, Liu Y, et al. Breast Milk Lipids and Fatty Acids in Regulating Neonatal Intestinal Development and Protecting against Intestinal Injury. Nutrients 2020; 12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koletzko B. Human Milk Lipids. Ann Nutr Metab 2016; 69 Suppl 2:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koletzko B, Agostoni C, Bergmann R, et al. Physiological aspects of human milk lipids and implications for infant feeding: a workshop report. Acta Paediatr 2011; 100:1405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Harzer G, Haug M, Dieterich I, Gentner PR. Changing patterns of human milk lipids in the course of the lactation and during the day. Am J Clin Nutr 1983; 37:612.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khan S, Hepworth AR, Prime DK, et al. Variation in fat, lactose, and protein composition in breast milk over 24 hours: associations with infant feeding patterns. J Hum Lact 2013; 29:81.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin CR. Lipids and Fatty Acids in the Preterm Infant, Part 1: Basic Mechanisms of Delivery, Hydrolysis, and Bioavailability. NeoReviews 2015; 16:e160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bronsky J, Campoy C, Embleton N, et al. Palm Oil and Beta-palmitate in Infant Formula: A Position Paper by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition. J Pediatr Gastroenterol Nutr 2019; 68:742.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Moon K, Rao SC, Schulzke SM, et al. Longchain polyunsaturated fatty acid supplementation in preterm infants. Cochrane Database Syst Rev 2016; 12:CD000375.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lindquist S, Hernell O. Lipid digestion and absorption in early life: an update. Curr Opin Clin Nutr Metab Care 2010; 13:314.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perretta L, Ouldibbat L, Hagadorn JI, Brumberg HL. High versus low medium chain triglyceride content of formula for promoting short-term growth of preterm infants. Cochrane Database Syst Rev 2021; 2:CD002777.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Delplanque B, Gibson R, Koletzko B, et al. Lipid Quality in Infant Nutrition: Current Knowledge and Future Opportunities. J Pediatr Gastroenterol Nutr 2015; 61:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li F, Wu SS, Berseth CL, et al. Improved Neurodevelopmental Outcomes Associated with Bovine Milk Fat Globule Membrane and Lactoferrin in Infant Formula: A Randomized, Controlled Trial. J Pediatr 2019; 215:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Billeaud C, Puccio G, Saliba E, et al. Safety and tolerance evaluation of milk fat globule membrane-enriched infant formulas: a randomized controlled multicenter non-inferiority trial in healthy term infants. Clin Med Insights Pediatr 2014; 8:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Timby N, Domellöf E, Hernell O, et al. Neurodevelopment, nutrition, and growth until 12 mo of age in infants fed a low-energy, low-protein formula supplemented with bovine milk fat globule membranes: a randomized controlled trial. Am J Clin Nutr 2014; 99:860.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Colombo J, Harris CL, Wampler JL, et al. Improved Neurodevelopmental Outcomes at 5.5 Years of Age in Children Who Received Bovine Milk Fat Globule Membrane and Lactoferrin in Infant Formula Through 12 Months: A Randomized Controlled Trial. J Pediatr 2023; 261:113483.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Timby N, Adamsson M, Domellöf E, et al. Neurodevelopment and growth until 6.5 years of infants who consumed a low-energy, low-protein formula supplemented with bovine milk fat globule membranes: a randomized controlled trial. Am J Clin Nutr 2021; 113:586.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin CR, Cheesman A, Brown J, et al. Factors Determining Optimal Fatty Acid Absorption in Preterm Infants. J Pediatr Gastroenterol Nutr 2016; 62:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Casper C, Hascoet JM, Ertl T, et al. Recombinant Bile Salt-Stimulated Lipase in Preterm Infant Feeding: A Randomized Phase 3 Study. PLoS One 2016; 11:e0156071.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Perrin MT, Belfort MB, Hagadorn JI, et al. The Nutritional Composition and Energy Content of Donor Human Milk: A Systematic Review. Adv Nutr 2020; 11:960.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coppa GV, Gabrielli O, Pierani P, et al. Changes in carbohydrate composition in human milk over 4 months of lactation. Pediatrics 1993; 91:637.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Antonowicz I, Lebenthal E. Developmental pattern of small intestinal enterokinase and disaccharidase activities in the human fetus. Gastroenterology 1977; 72:1299.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mobassaleh M, Montgomery RK, Biller JA, Grand RJ. Development of carbohydrate absorption in the fetus and neonate. Pediatrics 1985; 75:160.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Francavilla R, Calasso M, Calace L, et al. Effect of lactose on gut microbiota and metabolome of infants with cow's milk allergy. Pediatr Allergy Immunol 2012; 23:420.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ziegler EE, Fomon SJ. Lactose enhances mineral absorption in infancy. J Pediatr Gastroenterol Nutr 1983; 2:288.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kobayashi A, Kawai S, Obe Y, Nagashima Y. Effects of dietary lactose and lactase preparation on the intestinal absorption of calcium and magnesium in normal infants. Am J Clin Nutr 1975; 28:681.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bode L. Human milk oligosaccharides: every baby needs a sugar mama. Glycobiology 2012; 22:1147.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Autran CA, Kellman BP, Kim JH, et al. Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in preterm infants. Gut 2018; 67:1064.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Masi AC, Embleton ND, Lamb CA, et al. Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis. Gut 2021; 70:2273.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vandenplas Y, Berger B, Carnielli VP, et al. Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula. Nutrients 2018; 10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marriage BJ, Buck RH, Goehring KC, et al. Infants Fed a Lower Calorie Formula With 2'FL Show Growth and 2'FL Uptake Like Breast-Fed Infants. J Pediatr Gastroenterol Nutr 2015; 61:649.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goehring KC, Marriage BJ, Oliver JS, et al. Similar to Those Who Are Breastfed, Infants Fed a Formula Containing 2'-Fucosyllactose Have Lower Inflammatory Cytokines in a Randomized Controlled Trial. J Nutr 2016; 146:2559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Puccio G, Alliet P, Cajozzo C, et al. Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial. J Pediatr Gastroenterol Nutr 2017; 64:624.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berger B, Porta N, Foata F, et al. Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics. mBio 2020; 11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Modi N, Uthaya S, Fell J, Kulinskaya E. A randomized, double-blind, controlled trial of the effect of prebiotic oligosaccharides on enteral tolerance in preterm infants (ISRCTN77444690). Pediatr Res 2010; 68:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boehm G, Lidestri M, Casetta P, et al. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed 2002; 86:F178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kapiki A, Costalos C, Oikonomidou C, et al. The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants. Early Hum Dev 2007; 83:335.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mihatsch WA, Hoegel J, Pohlandt F. Prebiotic oligosaccharides reduce stool viscosity and accelerate gastrointestinal transport in preterm infants. Acta Paediatr 2006; 95:843.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Westerbeek EA, Hensgens RL, Mihatsch WA, et al. The effect of neutral and acidic oligosaccharides on stool viscosity, stool frequency and stool pH in preterm infants. Acta Paediatr 2011; 100:1426.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Westerbeek EA, van den Berg JP, Lafeber HN, et al. Neutral and acidic oligosaccharides in preterm infants: a randomized, double-blind, placebo-controlled trial. Am J Clin Nutr 2010; 91:679.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Westerbeek EA, van den Berg A, Lafeber HN, et al. The effect of enteral supplementation of a prebiotic mixture of non-human milk galacto-, fructo- and acidic oligosaccharides on intestinal permeability in preterm infants. Br J Nutr 2011; 105:268.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Westerbeek EA, Mørch E, Lafeber HN, et al. Effect of neutral and acidic oligosaccharides on fecal IL-8 and fecal calprotectin in preterm infants. Pediatr Res 2011; 69:255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van den Berg JP, Westerbeek EA, van der Klis FR, et al. Neutral and acidic oligosaccharides supplementation does not increase the vaccine antibody response in preterm infants in a randomized clinical trial. PLoS One 2013; 8:e70904.
          </a>
         </li>
         <li class="breakAll">
          Human Milk Banking Association of North America. HMBANA Standards for Donor Human Milk Banking: An Overview. 2020. Available at: https://www.hmbana.org/file_download/inline/95a0362a-c9f4-4f15-b9ab-cf8cf7b7b866 (Accessed on January 22, 2021).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pound C, Unger S, Blair B. Pasteurized and unpasteurized donor human milk. Paediatr Child Health 2020; 25:549.
          </a>
         </li>
         <li class="breakAll">
          American Academy of Pediatrics Committee on Nutition. Appendix A: Composition of human milk. In: Pediatric Nutrition, 8th ed, Kleinman RE, Greer FR (Eds), American Academy of Pediatrics, 2014. p.1505.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pietrzak-Fiećko R, Kamelska-Sadowska AM. The Comparison of Nutritional Value of Human Milk with Other Mammals' Milk. Nutrients 2020; 12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gokçe İK, Oguz SS. Late onset hyponatremia in preterm newborns: is the sodium content of human milk fortifier insufficient? J Matern Fetal Neonatal Med 2020; 33:1197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abrams SA, Committee on Nutrition. Calcium and vitamin d requirements of enterally fed preterm infants. Pediatrics 2013; 131:e1676.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Faienza MF, D'Amato E, Natale MP, et al. Metabolic Bone Disease of Prematurity: Diagnosis and Management. Front Pediatr 2019; 7:143.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chacham S, Pasi R, Chegondi M, et al. Metabolic Bone Disease in Premature Neonates: An Unmet Challenge. J Clin Res Pediatr Endocrinol 2020; 12:332.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abrams SA. Zinc for preterm infants: Who needs it and how much is needed? Am J Clin Nutr 2013; 98:1373.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Staub E, Evers K, Askie LM. Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates. Cochrane Database Syst Rev 2021; 3:CD012797.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sinha B, Dudeja N, Chowdhury R, et al. Enteral Zinc Supplementation in Preterm or Low Birth Weight Infants: A Systematic Review and Meta-analysis. Pediatrics 2022; 150.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5047 Version 31.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="javascript:alert('بدون لینک');" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Nutritional Care of Preterm Infants: Scientific Basis and Practical Guidelines, Koletzko B, Poindexter B, Uauy R (Eds), Karger, 2014.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25174435" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : A systematic review and meta-analysis of the nutrient content of preterm and term breast milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Functional Aspect of Colostrum and Whey Proteins in Human Milk
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11242440" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Effects of milk-derived bioactives: an overview.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28925267" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Absolute Quantification of Human Milk Caseins and the Whey/Casein Ratio during the First Year of Lactation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1515752" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Re-evaluation of the whey protein/casein ratio of human milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2209513" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Gastric emptying in infants with or without gastro-oesophageal reflux according to the type of milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Composition of the mother’s milk I. Protein contents, amino acid composition, biological value. A review
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2801581" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Free amino acids in preterm and term milk from mothers delivering appropriate- or small-for-gestational-age infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Distribution of nitrogen and protein amino acids in human and in cow's milk
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The amino acid composition of human milk proteins
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : The amino acid composition of human milk proteins
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24288022" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Amino acid profiles in term and preterm human milk through lactation: a systematic review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11144435" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Free glutamine and glutamic acid increase in human milk through a three-month lactation period.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32547547" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Free Amino Acids in Human Milk: A Potential Role for Glutamine and Glutamate in the Protection Against Neonatal Allergies and Infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32547547" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Free Amino Acids in Human Milk: A Potential Role for Glutamine and Glutamate in the Protection Against Neonatal Allergies and Infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32092925" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Breast Milk Lipids and Fatty Acids in Regulating Neonatal Intestinal Development and Protecting against Intestinal Injury.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28103608" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Human Milk Lipids.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21535133" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Physiological aspects of human milk lipids and implications for infant feeding: a workshop report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6682283" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Changing patterns of human milk lipids in the course of the lactation and during the day.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22797414" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Variation in fat, lactose, and protein composition in breast milk over 24 hours: associations with infant feeding patterns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Lipids and Fatty Acids in the Preterm Infant, Part 1: Basic Mechanisms of Delivery, Hydrolysis, and Bioavailability
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31022096" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Palm Oil and Beta-palmitate in Infant Formula: A Position Paper by the European Society for Paediatric Gastroenterology, Hepatology, and Nutrition (ESPGHAN) Committee on Nutrition.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27995607" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Longchain polyunsaturated fatty acid supplementation in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20179589" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Lipid digestion and absorption in early life: an update.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33620090" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : High versus low medium chain triglyceride content of formula for promoting short-term growth of preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25883056" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Lipid Quality in Infant Nutrition: Current Knowledge and Future Opportunities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31668885" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Improved Neurodevelopmental Outcomes Associated with Bovine Milk Fat Globule Membrane and Lactoferrin in Infant Formula: A Randomized, Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25452707" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Safety and tolerance evaluation of milk fat globule membrane-enriched infant formulas: a randomized controlled multicenter non-inferiority trial in healthy term infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24500150" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Neurodevelopment, nutrition, and growth until 12 mo of age in infants fed a low-energy, low-protein formula supplemented with bovine milk fat globule membranes: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37192722" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Improved Neurodevelopmental Outcomes at 5.5 Years of Age in Children Who Received Bovine Milk Fat Globule Membrane and Lactoferrin in Infant Formula Through 12 Months: A Randomized Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33564853" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Neurodevelopment and growth until 6.5 years of infants who consumed a low-energy, low-protein formula supplemented with bovine milk fat globule membranes: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26252920" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Factors Determining Optimal Fatty Acid Absorption in Preterm Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27244221" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Recombinant Bile Salt-Stimulated Lipase in Preterm Infant Feeding: A Randomized Phase 3 Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32119744" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : The Nutritional Composition and Energy Content of Donor Human Milk: A Systematic Review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8441573" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Changes in carbohydrate composition in human milk over 4 months of lactation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/558125" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Developmental pattern of small intestinal enterokinase and disaccharidase activities in the human fetus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2578223" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Development of carbohydrate absorption in the fetus and neonate.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22435727" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Effect of lactose on gut microbiota and metabolome of infants with cow's milk allergy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6875753" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Lactose enhances mineral absorption in infancy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1173736" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Effects of dietary lactose and lactase preparation on the intestinal absorption of calcium and magnesium in normal infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22513036" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Human milk oligosaccharides: every baby needs a sugar mama.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28381523" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Human milk oligosaccharide composition predicts risk of necrotising enterocolitis in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33328245" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Human milk oligosaccharide DSLNT and gut microbiome in preterm infants predicts necrotising enterocolitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30149573" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Human Milk Oligosaccharides: 2'-Fucosyllactose (2'-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26154029" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Infants Fed a Lower Calorie Formula With 2'FL Show Growth and 2'FL Uptake Like Breast-Fed Infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27798337" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Similar to Those Who Are Breastfed, Infants Fed a Formula Containing 2'-Fucosyllactose Have Lower Inflammatory Cytokines in a Randomized Controlled Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28107288" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Effects of Infant Formula With Human Milk Oligosaccharides on Growth and Morbidity: A Randomized Multicenter Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32184252" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Linking Human Milk Oligosaccharides, Infant Fecal Community Types, and Later Risk To Require Antibiotics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20639792" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : A randomized, double-blind, controlled trial of the effect of prebiotic oligosaccharides on enteral tolerance in preterm infants (ISRCTN77444690).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11978748" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16978805" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : The effect of a fructo-oligosaccharide supplemented formula on gut flora of preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16801182" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Prebiotic oligosaccharides reduce stool viscosity and accelerate gastrointestinal transport in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21449921" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : The effect of neutral and acidic oligosaccharides on stool viscosity, stool frequency and stool pH in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20032496" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Neutral and acidic oligosaccharides in preterm infants: a randomized, double-blind, placebo-controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20863418" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : The effect of enteral supplementation of a prebiotic mixture of non-human milk galacto-, fructo- and acidic oligosaccharides on intestinal permeability in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21228732" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Effect of neutral and acidic oligosaccharides on fecal IL-8 and fecal calprotectin in preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23951035" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Neutral and acidic oligosaccharides supplementation does not increase the vaccine antibody response in preterm infants in a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23951035" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Neutral and acidic oligosaccharides supplementation does not increase the vaccine antibody response in preterm infants in a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33365109" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Pasteurized and unpasteurized donor human milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33365109" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Pasteurized and unpasteurized donor human milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32422857" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : The Comparison of Nutritional Value of Human Milk with Other Mammals' Milk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30149743" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Late onset hyponatremia in preterm newborns: is the sodium content of human milk fortifier insufficient?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23629620" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Calcium and vitamin d requirements of enterally fed preterm infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31032241" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Metabolic Bone Disease of Prematurity: Diagnosis and Management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31674171" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Metabolic Bone Disease in Premature Neonates: An Unmet Challenge
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24132977" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Zinc for preterm infants: Who needs it and how much is needed?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33710626" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Enteral zinc supplementation for prevention of morbidity and mortality in preterm neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35921675" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Enteral Zinc Supplementation in Preterm or Low Birth Weight Infants: A Systematic Review and Meta-analysis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
